, Tracking Stock Market Picks
Enter Symbol:
Repligen Corporation (RGEN) [hlAlert]

up 525.09 %

Repligen Corporation (RGEN) rated Buy by Merriman

Posted on: Tuesday,  Jun 30, 2009  8:25 AM ET by Merriman

Merriman rated Buy Repligen Corporation (NASDAQ: RGEN) on 06/30/2009, when the stock price was $5.50. Since
then, Repligen Corporation has gained 525.09% as of 01/11/2016's recent price of $34.38.
If you would have followed this Merriman's recommendation on RGEN, you would have gained 525.09% of your investment in 2386 days.

Repligen Corporation develops new drugs based on naturally occurring peptides and proteins for autism, organ transplantation and immunesystem diseases. The company's lead therapeutic products are secretin for autism and CTLA4-Ig for organ transplantation and autoimmune diseases. The company manufactures and markets products based on Protein A for the purification of antibodies, and it owns commercial rights to products based on synthetic forms of secretin for the diagnosis of pancreatic function.

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/30/2009 8:25 AM Buy
as of 12/31/2009
1 Week up  25.65 %
1 Month up  2.12 %
3 Months down  -4.19 %
1 YTD down  -12.72 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy